Investment Insights News 12 January 2026

Singapore Exchange (SGX) stock edges down as bond futures plan emerges; Feb 5 results ahead

Singapore, Jan 14, 2026, 15:35 SGT — Regular session Shares of Singapore Exchange Ltd slipped slightly on Wednesday, with investors digesting reports that the bourse is considering adding new Asian government bond futures. By 3:35 p.m. Singapore time, the stock

14 January 2026

Financial Results·Investment Insights·Stock Market

Sembcorp Industries stock slips in Singapore as Alinta timeline looms — what to watch next

SINGAPORE, Jan 14, 2026, 15:38 SGT — Regular session Sembcorp Industries shares slipped Wednesday afternoon, last seen at S$5.97 after fluctuating between S$5.96 and S$6.02, per Investing data. The pullback arrives as investors await developments in Sembcorp’s planned acquisition of

14 January 2026

Energy Sector·Investment Insights·Market Analysis·Stock Market

Genting Singapore stock edges up as Singapore market holds firm — what traders watch next

Singapore, Jan 14, 2026, 15:11 SGT — Regular session Genting Singapore shares rose 0.7% to S$0.735 by 2:56 p.m. in Singapore on Wednesday, with about 2.6 million shares traded. (StockAnalysis) The move matters because Genting is still a simple proxy

14 January 2026

Investment Insights·Market Trends·Stock Market·Trading Strategies

ZIM stock edges up in premarket after a 52-week high run — what traders watch next

New York, Jan 13, 2026, 07:46 EST — Premarket ZIM Integrated Shipping Services Ltd (NYSE:ZIM) edged up 0.6% in early premarket trading Tuesday, reaching $23.40 after a solid jump the day before. (Public) The Israel-based container carrier closed Monday 3.9%

13 January 2026

Financial News·Investment Insights·Market Analysis·Stock Market·Trading Strategies

L3Harris (LHX) stock jumps premarket on Pentagon’s $1 billion Missile Solutions IPO plan

NEW YORK, Jan 13, 2026, 08:02 EST — Premarket L3Harris Technologies (LHX) shares surged roughly 10% to $376.04 in premarket trading Tuesday following the announcement of its plan to spin off the Missile Solutions unit, supported by a $1 billion

13 January 2026

Defense Industry·Financial Updates·Investment Insights·IPO News·Stock Market

Beam Therapeutics stock today: BEAM edges lower premarket after FDA alignment sparks 22% rally

New York, Jan 13, 2026, 05:28 ET — Premarket Beam Therapeutics Inc (BEAM.O) slipped roughly 0.6% to $33.47 in premarket trading Tuesday, following a sharp 22.3% jump during Monday’s session. The shares climbed as high as $36.44 Monday and saw

13 January 2026

Biotech News·FDA Updates·Investment Insights·Market Trends·Stock Market

Woodside Energy stock dips after Scarborough LNG milestone — what matters before the next ASX session

Sydney, Jan 13, 2026, 17:31 AEDT — Trading after hours. Woodside Energy Group Ltd shares slipped 1.7% to close at A$23.31 on Tuesday, following news that the floating production unit for its Scarborough gas project reached the offshore field near

13 January 2026

ASX News·Energy Sector·Investment Insights·Stock Market

Amphenol stock pops after $10.5B CommScope CCS deal closes — what to watch next

New York, January 12, 2026, 19:50 EST — Trading after hours. Amphenol Corp shares stayed steady in after-hours Monday following the completion of its $10.5 billion cash deal to acquire CommScope’s Connectivity and Cable Solutions business. Wall Street views the

13 January 2026

Business Analysis·Investment Insights·Stock Market·Technology News

Nebius stock pops near 10% after the close — what traders watch next for NBIS

New York, Jan 12, 2026, 19:09 EST — After-hours Nebius Group N.V. shares climbed roughly 9.6% to $107.33 in late Monday trading, after moving between $96.32 and $108.64 earlier in the session. Trading volume hit around 16 million shares. This

13 January 2026

Financial News·Investment Insights·Market Analysis·Stock Market·Trading Strategies

Mesoblast (MESO) stock drops 11% as traders digest insider buy and Ryoncil sales backdrop

New York, Jan 12, 2026, 15:14 (EST) — Regular session Mesoblast Ltd’s shares on the U.S. market dropped roughly 11% Monday, sliding to $18.64 in afternoon trading after hitting $20.14 earlier. The Australian biotech’s stock has seen sharp swings since

12 January 2026

Biotech Industry·Insider Trading·Investment Insights·Stock Market News

Sarepta stock sinks as Elevidys sales miss, flu delays spill into 2026

New York, Jan 12, 2026, 14:53 EST — Regular session. Sarepta Therapeutics shares dropped roughly 13% to $20.73 in Monday afternoon trading following a disappointing sales forecast for its Duchenne muscular dystrophy gene therapy, Elevidys, in the fourth quarter. This

12 January 2026

Biotech Stocks·Investment Insights·Market Analysis·Pharmaceutical News

Micron stock barely budges as exec warns DRAM crunch may last until 2028

New York, Jan 12, 2026, 12:24 EST — Regular session Micron Technology shares barely moved Monday after a company executive warned that the DRAM shortage—used in servers, PCs, and phones—might not ease significantly until 2028. The remarks come at a

12 January 2026

Investment Insights·Semiconductor Industry·Stock Market·Technology News

Investment Insights News 12 January 2026 - 14 January 2026